Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Leiomyosarcoma metastatic: Which Medications Are Safest? (50 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

50 medications are used for Leiomyosarcoma metastatic, with 302 combined adverse event reports. The most reported drugs for Leiomyosarcoma metastatic are TRABECTEDIN and DOXORUBICIN.

302
Total Reports
50
Drugs Used

All Medications for Leiomyosarcoma metastatic Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
TRABECTEDIN YONDELIS 79 376 896 19.2%
DOXORUBICIN Doxorubicin Hydrochloride 77 15,653 28,630 18.9%
DOCETAXEL Docetaxel 61 6,068 13,463 9.3%
GEMCITABINE Gemcitabine 58 5,142 12,268 16.4%
PAZOPANIB Pazopanib 39 5,612 4,347 26.5%
GEMCITABINE\GEMCITABINE - 28 2,206 3,666 21.6%
IFOSFAMIDE IFEX 21 3,365 5,230 19.8%
OLARATUMAB - 13 109 169 19.3%
PEMBROLIZUMAB KEYTRUDA 13 15,543 35,472 18.6%
DACARBAZINE Dacarbazine 12 847 1,914 16.6%
MESNA mesna 10 1,029 2,155 21.0%
CABOZANTINIB S-MALATE CABOMETYX 8 4,203 6,193 10.7%
ERIBULIN eribulin mesylate 8 793 2,642 15.7%
PACLITAXEL PACLITAXEL PACLITAXEL 8 12,030 31,638 15.6%
CARBOPLATIN Carboplatin 6 12,544 35,869 14.9%
NIVOLUMAB OPDIVO 5 23,086 36,530 26.3%

View all 50 drugs →

Most Reported Drugs for Leiomyosarcoma metastatic

#1 most reported
#2 most reported
#3 most reported